Incidental Pulmonary Nodules - What Do We Know in 2022

Area of Science:

• Oncology
• Radiology
• Pulmonology

Background:

• Lung cancer (LC) is a leading cause of cancer mortality globally.
• Early diagnosis significantly improves patient outcomes and survival rates.
• Low-dose computed tomography (CT) screening aims for early LC detection, but adoption is slow.

Purpose of the Study:

• To review the current management of incidentally detected pulmonary nodules (IPNs).
• To highlight recent advancements in IPN work-up processes.
• To explore strategies for improving early-stage LC diagnosis through IPN management.

Main Methods:

• Review of current literature and clinical practices regarding IPN assessment.
• Analysis of challenges in current IPN management.
• Evaluation of emerging technologies and programs for IPN processing.

Main Results:

• CT scans frequently detect IPNs, presenting a major opportunity for early LC diagnosis.
• Current IPN management is often suboptimal due to reporting issues, communication gaps, and unclear responsibilities.
• New approaches like AI and patient tracking software show promise in addressing these shortcomings.

Conclusions:

• Optimizing the evaluation and management of IPNs is crucial for advancing early-stage LC diagnosis.
• Systematic improvements in IPN processing can lead to a significant stage shift in lung cancer care.
• Further integration of technological solutions and clear protocols is needed for effective IPN management.